Anvisa restricted compassionate use of polilaminina to spinal cord injuries in the thoracic region, within 72 hours of onset. Criteria follow phase 1 clinical study results. Access limited to patients with T2 to T10 vertebrae injuries.
https://redir.folha.com.br/redir/online/emcimadahora/rss091/*https://www1.folha.uol.com.br/equilibrioesaude/2026/10/anvisa-restringe-uso-compassivo-da-polilaminina-e-rebate-criticas-de-tatiana-coelho-de-sampaio.shtml
#anvisa #polilaminina #spinal #injury #medication
https://redir.folha.com.br/redir/online/emcimadahora/rss091/*https://www1.folha.uol.com.br/equilibrioesaude/2026/10/anvisa-restringe-uso-compassivo-da-polilaminina-e-rebate-criticas-de-tatiana-coelho-de-sampaio.shtml
#anvisa #polilaminina #spinal #injury #medication
Views: 1
Categories: News & Updates [c3]